Abstract
A Phase 1/2 Study of INCB000928 As Monotherapy or in Combination with Ruxolitinib in Patients with Anemia Due to Myelofibrosis (INCB 00928-104)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have